Market revenue in 2023 | USD 124.5 million |
Market revenue in 2030 | USD 320.4 million |
Growth rate | 14.5% (CAGR from 2023 to 2030) |
Largest segment | Hydrogels |
Fastest growing segment | Nanofiber Based Scaffolds |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Tecan Group AG, Becton Dickinson & Co, Medtronic PLC, Matricelf Ltd, Corning Inc, Avacta Group PLC, Vericel Corp, NuVasive, Allergan, ReproCELL, 3D Biotek, Xanofi, Molecular Matrix, Pelo Biotech, Azenta Life Sciences, Akron Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scaffold technology market will help companies and investors design strategic landscapes.
Hydrogels was the largest segment with a revenue share of 41.69% in 2023. Horizon Databook has segmented the Canada scaffold technology market based on hydrogels, polymeric scaffolds, micropatterned surface microplates, nanofiber based scaffolds covering the revenue growth of each sub-segment from 2018 to 2030.
The Canadian scaffold technology market is expected to register lucrative growth in the coming years, owing to continual improvements in 3D cell culture technology. A recent study published in May 2019 by Santiago Campuzano and Andrew E. Pelling stated that the development and utilization of 3D scaffolds enable customers to efficiently mimic in vivo environment of cells.
The researchers from University of Ottawa presented three animal-free scaffolds, namely, chitin/chitosan, decellularized plant tissue, and recombinant collagen, which showed potential scalability and tenability in cellular agriculture and food technologies applications.
Moreover, companies are gaining approvals from Canadian government to conduct scaffold-related clinical trials. For instance, in March 2017, Cambridge-based InVivo Therapeutics received approval from Health Canada to conduct a clinical study of its neuro-spinal scaffold in treatment of acute AIS A cervical spinal cord injuries.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada scaffold technology market , including forecasts for subscribers. This country databook contains high-level insights into Canada scaffold technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account